XML 31 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 14 - Restructuring
6 Months Ended
Jun. 30, 2018
Notes to Financial Statements  
Restructuring and Related Activities Disclosure [Text Block]
14
.
Restructuring
 
In
March 2018,
the Company announced its plans to close its leased Permalok® manufacturing facility in Salt Lake City, Utah and move the production to the Permalok® production facility in St. Louis, Missouri, which was completed during the
second
quarter of
2018.
Also in
March 2018,
the Company announced its plans to close its manufacturing facility in Monterrey, Mexico, and ceased production early in the
second
quarter of
2018.
The Company incurred restructuring expense of
$0.8
 million and
$1.1
 million during the
three
and
six
months ended
June 
30,
2018,
which includes employee severance and termination related restructuring expense of
$0.4
 million and
$0.6
 million, respectively, and expense related to demobilization activities of
$0.4
 million and
$0.5
 million, respectively. The Company expects to incur additional restructuring expense of
$0.1
 million related to employee severance and termination which will result in future cash outlays.
 
In
October 2016,
the Company sold the Denver, Colorado facility and leased the property back from the buyer through
March 
1,
2017
in order to conclude production at the facility, complete final shipments and transfer certain equipment assets to other Company facilities. The Company incurred restructuring expense of
$0.9
 million during the
six
months ended
June 
30,
2017
related to demobilization activities. The Company completed the demobilization project and vacated the facility in the
first
quarter of
2017
and there were
no
restructuring expenses in the
three
months ended
June 
30,
2017.